Mural Oncology plc
MURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $54,595 | $98,803 | $63,415 | $63,415 |
| - Cash | $115,462 | $270,852 | -$19,386 | -$25,306 |
| + Debt | $8,022 | $15,009 | $19,386 | $25,306 |
| Enterprise Value | -$52,845 | -$157,040 | $102,187 | $114,027 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$3,512 | -$2,567 | $0 | -$1,474 |
| % Margin | – | – | – | – |
| EBITDA | -$125,002 | -$192,720 | -$183,383 | -$173,891 |
| % Margin | – | – | – | – |
| Net Income | -$128,514 | -$207,447 | -$189,807 | -$175,433 |
| % Margin | – | – | – | – |
| EPS Diluted | -7.58 | -12.43 | -11.37 | -10.51 |
| % Growth | 39% | -9.3% | -8.2% | – |
| Operating Cash Flow | -$128,545 | -$194,249 | -$168,588 | -$156,668 |
| Capital Expenditures | -$92 | -$3,452 | -$5,511 | -$4,385 |
| Free Cash Flow | -$128,637 | -$197,701 | -$174,099 | -$161,053 |